title: Medicare proposal may benefit insurers.
abstract: The proposed guidelines from U.S. Pharmacopeial Convention Inc., which was assigned the task by last year's Medicare law, seek a middle ground between pharmaceutical companies and insurers. The USP proposal is expected to result in a final plan after the organization takes comments. It is also supposed to define a list of classes of drugs--more formally divided into therapeutic areas and pharmacologic subcategories.
authors.affiliation: Navigant Consultingin Chicago, Illinois, USA. afine@navigantconsulting.com
authors.forename: Allan
authors.initials: A
authors.lastname: Fine
mesh_terms: D004345:Drug Industry; D005569:Formularies as Topic; D017408:Guidelines as Topic; D008329:Managed Care Programs; D006278:Medicare; D014481:United States